Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell CancersB-cell chronic lymphocytic leukemia, B-cell neoplasm, Blood Protein Disorders, Burkitt lymphoma, Chronic Disease, DNA Virus Infections, Disease Attributes, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Leukemia, B-Cell, Lymphoma, B-Cell, Marginal Zone, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tumor Virus Infections, Waldenstrom macroglobulinemia, cardiovascular disorder, diffuse large B-cell lymphoma, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, marginal zone lymphoma, monoclonal gammopathy, neoplasm, plasma cell neoplasm, primary central nervous system lymphoma, vascular disorder, vascular hemostatic disease, viral infectious diseaseActive, not recruitingPhase 12026-08-27NCT04464200

2 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Memorial Sloan Kettering Cancer Center753
Takeda163

7 results · Page 1 of 1